Baird Reiterates Outperform on Affymax, Inc. with $20 Price Target

August 9, 2012 11:57 AM EDT Send to a Friend
Get Alerts AFFY Hot Sheet
Price: $1.40 -3.45%

Rating Summary:
    6 Buy, 4 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 28 | New: 14
Trade AFFY Now!
Today analysts at Baird reiterated their Outperform rating on Affymax, Inc. (NASDAQ: AFFY) and moved their price target to $20.00.

“With Omontys launching late April, full sales capability not on-line till late June, and dialysis uptake notoriously slow, low Q212 expectations were validated,” said analysts. “However, with revelations of numerous MDO/SDO contracts (only one of which identified by name) and Fresenius conversion happening much faster than we had thought, we think Omontys may yet measurably beat our $20.6M FY12 estimate.”

For an analyst ratings summary and ratings history on Affymax, Inc. click here. For more ratings news on Affymax, Inc. click here.

Shares of Affymax, Inc. closed at $16.99 yesterday, with a 52 week range of $3.93-$17.33.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Robert W Baird

Add Your Comment